AGF Management Ltd. Buys 140 Shares of Danaher Co. (NYSE:DHR)

by · The Markets Daily

AGF Management Ltd. boosted its stake in shares of Danaher Co. (NYSE:DHR – Free Report) by 1.6% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 8,940 shares of the conglomerate’s stock after acquiring an additional 140 shares during the quarter. AGF Management Ltd.’s holdings in Danaher were worth $2,052,000 as of its most recent SEC filing.

Several other large investors also recently added to or reduced their stakes in the stock. FMR LLC increased its stake in Danaher by 15.8% during the third quarter. FMR LLC now owns 23,617,424 shares of the conglomerate’s stock worth $6,566,116,000 after acquiring an additional 3,217,631 shares during the last quarter. Bank of New York Mellon Corp increased its stake in Danaher by 5.4% during the fourth quarter. Bank of New York Mellon Corp now owns 8,589,019 shares of the conglomerate’s stock worth $1,971,609,000 after acquiring an additional 441,012 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its stake in shares of Danaher by 3.0% during the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 5,097,986 shares of the conglomerate’s stock valued at $1,417,342,000 after buying an additional 148,251 shares during the last quarter. Fisher Asset Management LLC grew its stake in shares of Danaher by 0.6% during the fourth quarter. Fisher Asset Management LLC now owns 4,578,945 shares of the conglomerate’s stock valued at $1,051,097,000 after buying an additional 26,305 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. grew its stake in shares of Danaher by 3.4% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 4,066,755 shares of the conglomerate’s stock valued at $933,524,000 after buying an additional 135,047 shares during the last quarter. 79.05% of the stock is owned by institutional investors.

Danaher Stock Up 3.4 %

Danaher stock opened at $211.09 on Friday. Danaher Co. has a twelve month low of $196.80 and a twelve month high of $281.70. The business has a fifty day moving average of $220.07 and a two-hundred day moving average of $240.82. The company has a quick ratio of 1.05, a current ratio of 1.40 and a debt-to-equity ratio of 0.31. The firm has a market cap of $150.87 billion, a P/E ratio of 39.98, a P/E/G ratio of 2.66 and a beta of 0.82.

Danaher (NYSE:DHR – Get Free Report) last issued its quarterly earnings data on Wednesday, January 29th. The conglomerate reported $2.14 EPS for the quarter, meeting the consensus estimate of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same quarter last year, the firm posted $2.09 earnings per share. On average, analysts forecast that Danaher Co. will post 7.63 earnings per share for the current fiscal year.

Danaher Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be issued a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a dividend yield of 0.61%. The ex-dividend date of this dividend is Friday, March 28th. This is a positive change from Danaher’s previous quarterly dividend of $0.27. Danaher’s dividend payout ratio is currently 24.24%.

Insider Activity

In related news, SVP Brian W. Ellis sold 5,700 shares of the company’s stock in a transaction on Thursday, January 30th. The stock was sold at an average price of $224.13, for a total value of $1,277,541.00. Following the transaction, the senior vice president now directly owns 20,230 shares of the company’s stock, valued at $4,534,149.90. This represents a 21.98 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Company insiders own 11.10% of the company’s stock.

Analyst Ratings Changes

A number of research analysts have recently commented on DHR shares. Citigroup cut their target price on Danaher from $285.00 to $265.00 and set a “buy” rating on the stock in a research note on Thursday, January 30th. Royal Bank of Canada reaffirmed an “outperform” rating and set a $277.00 target price (down previously from $299.00) on shares of Danaher in a research note on Thursday, January 30th. The Goldman Sachs Group set a $250.00 target price on Danaher in a research note on Wednesday, January 15th. Raymond James reaffirmed a “market perform” rating on shares of Danaher in a research note on Monday, February 3rd. Finally, Stifel Nicolaus raised Danaher from a “hold” rating to a “buy” rating and set a $260.00 price objective on the stock in a research note on Friday. Six analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $277.76.

Read Our Latest Stock Analysis on Danaher

Danaher Profile

(Free Report)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

See Also

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR – Free Report).